Helmsley Charitable Trust Announces $5 Million Request for Proposals for Innovative uses of Type 1 Diabetes Data

The Type 1 Diabetes Program of The Leona M. and Harry B. Helmsley Charitable Trust has announced the launch of the Diabetes Data Innovation Initiative. The Trust has issued a request for proposals to identify high-potential projects and pioneering digital health solutions that could enable the integration of diabetes data to identify trends and develop personalized patient guidance and decision support for providers. Over the next two years, they will provide up to $5 million in funding for innovative solutions that enable the use of data to ease the burden of type 1 diabetes (T1D) for those living with the disease, their caregivers and healthcare providers.

Aggregating data and transforming it into actionable knowledge has the power to play a profound role in improving therapies and the overall daily management of the disease, resulting in better glucose control, health outcomes and quality of life. With this funding initiative, the Trust will consider new and advanced projects including, but not limited to, mobile platforms and applications, electronic medical records and electronic health records, embedded wireless sensors and communications, and big data analytics. Integration with consumer, patient and healthcare professional devices and platforms will likely be essential.

Over the past decade, advances in medical device technologies have made a significant impact on the monitoring, management and treatment of T1D. However, data from the T1D Exchange demonstrates that, due to the complexity of the disease, the majority of people with T1D are not achieving optimal health outcomes despite today’s tools, and many report feeling overwhelmed by information on insulin dosing, blood glucose values, exercise, meals and other sources.

Timeline:

  • Funding Opportunity Release Date - June 1, 2015
  • LOI Submission Deadline – July 20, 2015
  • Selected Applicants Proceed to Full Proposal - August 2015
  • Full Proposal Submission Deadline - October 5, 2015
  • Anticipated Commencement of Selected Programs - First Quarter, 2016

More information about the Diabetes Data Innovation Initiative and the related request for proposals can be found on the Trust’s website at www.helmsleytrust.org/diabetes-data-innovation-initiative.

About the Helmsley Charitable Trust
The Leona M. and Harry B. Helmsley Charitable Trust aspires to improve lives by supporting exceptional nonprofits and other mission-aligned organizations in health, selected place-based initiatives, and education and human services. Since 2008, when the Trust began its active grantmaking, it has committed more than $1 billion. The Helmsley Type 1 Diabetes Program is the largest private foundation funder of T1D in the United States focused on understanding the disease, developing better treatments and improving care and access.

Most Popular Now

Artificial Intelligence Solution Improve…

Clinical trials are a critical tool for getting new treatments to people who need them, but research shows that difficulty finding the right volunteer subjects can undermine the effectiveness of...

South West London Pathology Picks CliniS…

One of the first pathology networks in the country, set up to serve more than two million people in south west London, has signed a contract with CliniSys for a...

Call for Tenders: Studies on eHealth, In…

The European Commission is launching a tender for two studies to survey and analyse progress on the digital transformation of the health and care in the EU, in particular with...

AI-based AI-Rad Companion Chest CT Softw…

AI-Rad Companion Chest CT(1), an intelligent software assistant for radiology, was recently awarded the CE mark, which means Siemens Healthineers can start marketing this artificial intelligence (AI)-based software as a...

Spot On for Healthcare Technology Startu…

10 - 12 October 2019, Berlin, Germany. XPOMET Medicinale brings together care providers, patients, and in general stakeholders from all health-related fields and geographic regions. The Festival of Future Medicine and...

Isansys Named as Finalist for OBN's Most…

Isansys Lifecare is proud to announce it has been shortlisted in the Most Transformative Digital Healthcare Company category at the OBN Annual Awards 2019. The award recognises the significant uptake...

Allscripts Listed on Lot One of Health S…

Allscripts has been included on a new list of accredited suppliers of electronic patient records that has been published by NHS England and NHSX. The company is one of just...

How can We Successfully Converge the Hea…

Opinion Article by Erik Janssen, VP, Innovative Solutions, Neurology, UCB Pharma. The fourth industrial revolution is upon us and fundamentally changing the way we live, work and interact across all industries...

NHS Patient Safety Technology Provider P…

A technology company that has helped NHS hospitals in England and Scotland to quickly identify and respond to their sickest patients, will now be known as Alcidion. Patientrack, which is...

Carestream Health Completes Sale of Heal…

Carestream Healthhas completed the sale of the company's healthcare information solutions business to Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, in 26 of the 38...